Fig. 2From: Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumabMIDAS pain severity* over 2 years: A mean pain severity score ± standard error, and B mean change in pain severity score ± standard error. MIDAS, Migraine Disability Assessment. *Pain severity graded on 0‒10 scaleBack to article page